165 related articles for article (PubMed ID: 24684245)
1. Thyroid hormone supplementation in preterm infants born before 28 weeks gestational age and neurodevelopmental outcome at age 36 months.
van Wassenaer-Leemhuis A; Ares S; Golombek S; Kok J; Paneth N; Kase J; LaGamma EF
Thyroid; 2014 Jul; 24(7):1162-9. PubMed ID: 24684245
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental Outcomes at 42 Months After Thyroxine Supplementation in Infants Below 28 Weeks' Gestation: A Randomized Controlled Trial.
Ng SM; Turner MA; Weindling AM
Thyroid; 2020 Jul; 30(7):948-954. PubMed ID: 32070246
[No Abstract] [Full Text] [Related]
3. Postnatal thyroid hormone replacement in very preterm infants.
Kok JH; Briet JM; van Wassenaer AG
Semin Perinatol; 2001 Dec; 25(6):417-25. PubMed ID: 11778912
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants.
Osborn DA
Cochrane Database Syst Rev; 2001; (4):CD001070. PubMed ID: 11687092
[TBL] [Abstract][Full Text] [Related]
5. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
[TBL] [Abstract][Full Text] [Related]
6. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial.
van Wassenaer AG; Westera J; Houtzager BA; Kok JH
Pediatrics; 2005 Nov; 116(5):e613-8. PubMed ID: 16234230
[TBL] [Abstract][Full Text] [Related]
7. Impact of neonatal thyroid hormone insufficiency and medical morbidity on infant neurodevelopment and attention following preterm birth.
Simic N; Asztalos EV; Rovet J
Thyroid; 2009 Apr; 19(4):395-401. PubMed ID: 19355829
[TBL] [Abstract][Full Text] [Related]
8. The quantity of thyroid hormone in human milk is too low to influence plasma thyroid hormone levels in the very preterm infant.
van Wassenaer AG; Stulp MR; Valianpour F; Tamminga P; Ris Stalpers C; de Randamie JS; van Beusekom C; de Vijlder JJ
Clin Endocrinol (Oxf); 2002 May; 56(5):621-7. PubMed ID: 12030913
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden.
Serenius F; Källén K; Blennow M; Ewald U; Fellman V; Holmström G; Lindberg E; Lundqvist P; Maršál K; Norman M; Olhager E; Stigson L; Stjernqvist K; Vollmer B; Strömberg B;
JAMA; 2013 May; 309(17):1810-20. PubMed ID: 23632725
[TBL] [Abstract][Full Text] [Related]
10. Trials with thyroid hormone in preterm infants: clinical and neurodevelopmental effects.
van Wassenaer AG; Kok JH
Semin Perinatol; 2008 Dec; 32(6):423-30. PubMed ID: 19007681
[TBL] [Abstract][Full Text] [Related]
11. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
[TBL] [Abstract][Full Text] [Related]
12. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial.
Uchiyama A; Kushima R; Watanabe T; Kusuda S
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):177-82. PubMed ID: 25153575
[TBL] [Abstract][Full Text] [Related]
13. Thyroid function in very preterm newborns: possible implications.
Van Wassenaer AG; Kok JH; Briët JM; Pijning AM; de Vijlder JJ
Thyroid; 1999 Jan; 9(1):85-91. PubMed ID: 10037082
[TBL] [Abstract][Full Text] [Related]
14. Two-year neurodevelopmental outcomes of extremely preterm infants treated with early hydrocortisone: treatment effect according to gestational age at birth.
Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
Arch Dis Child Fetal Neonatal Ed; 2019 Jan; 104(1):F30-F35. PubMed ID: 29321180
[TBL] [Abstract][Full Text] [Related]
15. Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks' gestation.
La Gamma EF; van Wassenaer AG; Ares S; Golombek SG; Kok JH; Quero J; Hong T; Rahbar MH; de Escobar GM; Fisher DA; Paneth N
Pediatrics; 2009 Aug; 124(2):e258-68. PubMed ID: 19581264
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal assessment of thyroid hormone concentrations in preterm infants younger than 30 weeks' gestation during the first 2 weeks of life and their relationship to outcome.
Biswas S; Buffery J; Enoch H; Bland JM; Walters D; Markiewicz M
Pediatrics; 2002 Feb; 109(2):222-7. PubMed ID: 11826199
[TBL] [Abstract][Full Text] [Related]
17. Supplemental Iodide for Preterm Infants and Developmental Outcomes at 2 Years: An RCT.
Williams FLR; Ogston S; Hume R; Watson J; Stanbury K; Willatts P; Boelen A; Juszczak E; Brocklehurst P;
Pediatrics; 2017 May; 139(5):. PubMed ID: 28557747
[TBL] [Abstract][Full Text] [Related]
18. An explanatory randomised placebo controlled trial of levothyroxine supplementation for babies born <28 weeks' gestation: results of the TIPIT trial.
Ng SM; Turner MA; Gamble C; Didi M; Victor S; Manning D; Settle P; Gupta R; Newland P; Weindling AM
Trials; 2013 Jul; 14():211. PubMed ID: 23841945
[TBL] [Abstract][Full Text] [Related]
19. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study.
Pierrat V; Marchand-Martin L; Arnaud C; Kaminski M; Resche-Rigon M; Lebeaux C; Bodeau-Livinec F; Morgan AS; Goffinet F; Marret S; Ancel PY;
BMJ; 2017 Aug; 358():j3448. PubMed ID: 28814566
[No Abstract] [Full Text] [Related]
20. Evolution of circulating thyroid hormone levels in preterm infants during the first week of life: perinatal influences and impact on neurodevelopment.
Eerdekens A; Naulaers G; Ortibus E; Verhaeghe J; Langouche L; Vanhole C
J Pediatr Endocrinol Metab; 2019 Jun; 32(6):597-606. PubMed ID: 31112508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
